(1)
Molecular Docking Study of α-, β-, and γ-Mangostin from Mangosteen (Garcinia Mangostana L.) Targeting VEGFR-2 and NRP-1 for Anti-Angiogenic Therapeutics in Retinopathy Diabetic. EPHELS 2025, 17, 10-21. https://doi.org/10.55549/ephels.145.